You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 30, 2018

Vietnam: Examining the NOIP’s Approach to Post-Grant Correction of Patents

Managing Intellectual Property

In Vietnam, granted patents can be amended in certain circumstances under provisions found in the Law on Intellectual Property (IP Law). For example, Article 97 of the IP Law gives a patent owner the right to request correction of errors made by the National Office of Intellectual Property (NOIP) in a granted patent.

The law is silent regarding correction of errors made by other parties, such as the patent owner itself, or its local patent agent. However, to ensure the accuracy of a patent, common sense dictates that correctable errors should not be limited to those made by the NOIP, but should extend to any other obvious errors.

In practice, a patent owner can request the NOIP to correct obvious errors that are not clearly the fault of the NOIP. However, there is no definition in Vietnamese legal documents of what constitutes an “obvious error.” A recent case involving a European pharmaceutical company brought this issue to the forefront.

Post-Grant Correction Rejected

The company in question holds a Vietnamese patent that was granted nearly a decade ago for a compound for the treatment of a medical condition. The company is now battling infringing generic products in the Vietnam market, but faced a temporary setback when it discovered, in the course of litigation, that its patent had an error in the chemical formula (structural formula) of the compound, although the compound name was written correctly.

It is worth noting that the patent originated from a foreign priority document, which was enclosed with the Vietnam application, in which the correct structural formula and compound name were shown. It is likely that the error was introduced during the translation of the patent specification into Vietnamese by a local patent agent.

As a result of this error, the company recognized that enforcement efforts could be hindered, as generic producers could argue that they were not technically infringing the patent, because the compound in their products was not the same as the patented compound, based on the (erroneous) structural formula in a claim of the granted patent.

The company thus proactively petitioned for a correction of the granted patent, reasoning that the error in the structural formula was obvious and should have been readily apparent to a person having ordinary skill in the art. The examiner in charge of the patent certainly should have had the capacity to discover the error before granting the patent, having reviewed the priority document and the corresponding patents issued previously by other patent offices, which all showed the correct structural formula. The NOIP, however, refused to correct the patent, claiming that the error was not obvious.

What Makes an Error Obvious?

The NOIP’s refusal notice referred to some concepts of obvious errors in the case law of the Boards of Appeal of the European Patent Office (EPO), and also stated that the NOIP considers these concepts to be appropriate. Specifically, the NOIP cited Point 4.2 in the Case Law, that for a correction to be made, it must be established that:

it is obvious that an error is in fact present in the document filed with the EPO, the incorrect information having to be objectively recognizable [emphasized in the NOIP’s notice] by the skilled person using common general knowledge.

The NOIP argued that if the patent owner did not notice the error within the two-year patent examination period, let alone for nearly 10 years thereafter, it could hardly be considered “obvious.” In addition, the same error appeared in other applications and patents of the company related to the compound.

While the patent application in question referred to the correct description in the EP patent, the incorrect structural formula consistently appeared throughout the summary, description, and claims of the Vietnamese application itself, and the NOIP further asserted that it had no obligation to consider other documents, referring to Point 4.2.1 of the case law:

On the other hand, documents, even if they were filed together with the European patent application, such as priority documents and the abstract may not be used.

Outlook

The arguments in the NOIP’s refusal notice signal that the NOIP intends to follow the EPO’s practice regarding obvious errors and their corrections (though it is debatable that the EPO would have come to the same conclusion in a similar situation). Historically, however, the NOIP’s practice has not always been consistent, and it is unclear to what extent patent correction will be allowed in the future. To ensure their patent rights in Vietnam, practitioners and applicants would be well advised to review their applications very carefully, and rely only on reputable, experienced IP agents, with the most accurate translation capacity, for patent prosecution, to avoid unexpected consequences.

RELATED INSIGHTS​ 

September 14, 2026
Myanmar’s first-to-file trademark registration regime under the Trademark Law 2019—which became fully operational in April 2023—provides mark owners with enhanced legal protection compared with the country’s former system. Correspondingly, the current system imposes more rigorous statutory requirements for obtaining, maintaining, and enforcing rights in marks. In this first-to-file trademark registration system, however, evidence of use remains particularly significant, as it may establish acquired distinctiveness, support a claim that a mark is well-known, and strengthen the owner’s position in both registration and enforcement proceedings. Accordingly, it can be said that this framework is underpinned by three key concepts: distinctiveness, well-known status, and, importantly, use of the trademark. Trademark Distinctiveness Under the Trademark Law, signs that lack distinctiveness are generally ineligible for mark protection. These signs include generic terms, basic shapes, unstylized single letters or numerals, and signs that merely describe the kind, quality, quantity, intended purpose, value, geographical origin, production time, or other characteristics of the relevant goods or services. However, a mark that would otherwise be refused on distinctiveness or descriptiveness grounds may be registrable if it has acquired distinctiveness through its use prior to the filing date. To show this, the applicant must demonstrate that the mark became distinctive to relevant consumers through continuous, exclusive, and good-faith use in trade within Myanmar. The burden of proving acquired distinctiveness rests with the mark owner. Accordingly, sufficient evidence demonstrating both use of the mark and the level of consumer recognition attained should be prepared in advance. Well-Known Mark Criteria Myanmar’s Trademark Rules, which govern the substantive examination of mark registration applications, establish criteria for determining well-known marks, aligned with international standards. Where an applicant claims well-known status—whether to overcome a refusal on relative grounds or to oppose a third party’s registration—the registrar will assess the claim based on the following
September 14, 2026
On August 23, 2026, Vietnam’s National Assembly passed Law No. 11/2026/QH16, amending the country’s Customs Law with effect from March 1, 2027. The amendments represent a substantial reform of Vietnam’s customs-based intellectual property enforcement regime. The reforms come amid considerable external pressure. In its 2026 Special 301 review, the US Trade Representative (USTR) designated Vietnam a “priority foreign country,” citing widespread counterfeiting, weak border enforcement, limited ex officio customs powers, and the absence of controls over goods in transit. Vietnam’s legislative response signals a commitment to bringing its border enforcement practices into line with international expectations. For IP rights holders operating in or through Vietnam, the amended law introduces several tools that substantially strengthen enforcement options at the border. Closing the Transit Gap One of the most consequential amendments is the extension of IP-related customs enforcement to goods in transit. Previously, Vietnam’s customs regime applied IP controls only to goods being imported or exported, a gap the USTR had specifically identified as enabling infringing goods to pass through Vietnamese ports with impunity. Vietnam’s geographic position as a logistics hub for Southeast Asia means that substantial volumes of goods transit its ports and free-trade zones. Extending enforcement to cover these shipments brings Vietnam closer to the standard set by the EU’s customs enforcement regulation and addresses a longstanding concern of multinational brand owners whose goods are frequently counterfeited in the region. Strengthened Suspension and Ex Officio Powers The amended law introduces a dual-track suspension mechanism (Article 73(2)). Customs authorities will suspend clearance upon request by an IP rights holder (or authorized representative) who provides evidence of IP ownership, evidence of infringement, and a financial guarantee. Customs can now proactively suspend clearance on an ex officio basis if, during inspection and monitoring, they discover “clear grounds” to suspect that imported, exported,
September 7, 2026
Indonesia’s Constitutional Court (Mahkamah Konstitusi) has reinstated a key provision limiting pharmaceutical patent protection, signaling a renewed commitment to balancing patent rights with public access to medicines. In its ruling to Case No. 255/PUU-XXIII/2025, the court partially granted a petition for judicial review of Law No. 65 of 2024, which had amended the country’s Patent Law, and ordered the restoration of a provision that had excluded certain pharmaceutical inventions from patentability. The decision took effect immediately upon its pronouncement at the court’s plenary session on August 28, 2026. Background The petition challenged the removal of article 4(f) from Law No. 13 of 2016 concerning Patents (Patent Law), as amended by Law No. 65 of 2024. Article 4(f) had excluded from patentability certain inventions relating to new uses of known substances. The petitioners argued that removing this provision would open the door to patent protection for second medical use inventions and facilitate patent evergreening—practices that can extend exclusivity periods, delay generic market entry, and reduce public access to affordable medicines. The petitioners included several patient advocacy and public-interest organizations: the Indonesian Dialysis Patients Community Association, the Indonesian Association of Drug Abuse Victims (PKNI), the Indonesian Pulmonary Hypertension Foundation (YHPI), the Rekat Peduli Indonesia Foundation, and the Indonesian Positive Women’s Association (IPPI), along with the Indonesia for Global Justice Association and four individual petitioners. The petitioners also challenged the constitutionality of the phrase “interested party” in article 70(1) of the Patent Law, arguing that it should be construed expressly to clarify who has standing to appeal a decision to grant a patent before the Board of Patent Appeal, and to allow a broader range of parties—such as patent holders, licensees, consumer organizations, prosecutors, aggrieved third parties, and others who may suffer direct or indirect harm from the grant of a patent—to
September 2, 2026
Thailand and China have a longstanding and significant trade relationship, which increasingly extends to e-commerce and digitally enabled supply chains. While these channels create new opportunities for businesses to reach consumers across borders, their growth also brings greater exposure to intellectual property (IP) infringement across jurisdictions and online platforms. Effective cooperation between the two countries’ enforcement authorities has therefore become increasingly important. To strengthen cooperation in this area, Thailand and China signed a memorandum of understanding (MOU) on IP enforcement in Beijing on July 20, 2026, during the Thai prime minister’s official visit to China. Officially titled “Memorandum of Understanding Between the State Administration for Market Regulation of the People’s Republic of China and the Ministry of Commerce of the Kingdom of Thailand on Cooperation in the Field of Intellectual Property Enforcement,” the MOU forms part of a broader bilateral agenda covering industrial and supply chains, participation by micro, small, and medium-sized enterprises (MSMEs), cooperation associated with the ASEAN–China Free Trade Area 3.0, and progress on the registration of Thai geographical indications in China. The MOU establishes a bilateral framework for cooperation and coordination in five broad areas: Strengthening dialogue in IP enforcement; Enhancing information sharing; Facilitating the enforcement of IP rights in cases arising in the parties’ domestic markets and on online platforms, in accordance with their respective domestic laws; Promoting cooperation in IP enforcement training and human resource development; and Undertaking other cooperation activities agreed upon by both sides. The Department of Intellectual Property (DIP) will serve as the principal coordinating agency for Thailand, while the Bureau of Law Enforcement and Inspection in China’s State Administration for Market Regulation (SAMR) will serve in that role for China. The framework is particularly relevant to the growth of e-commerce, as it covers infringement in the domestic markets and on